FDA inspection
Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.: FDA inspection ending Apr 12, 2018
FDA inspection 1052732 · No Action Indicated (NAI) · Hohhot
Key facts
| Inspection ID | 1052732 |
|---|---|
| Firm | Qilu Pharmaceutical (Inner Mongolia) Co., Ltd. |
| FEI number | 3013144860 |
| Address | Jinchuannan Economic & Tech Dev. Zone, 2 Wei Si Road |
| City | Hohhot |
| Country | China |
| Fiscal year | 2018 |
| Inspection end date | Apr 12, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Pre-Approval Eval. of Animal Drugs and Food Additives |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data